Perlecan Diversely Regulates the Migration and Proliferation of Distinct Cell Types in vitro

Cells Tissues Organs

Volumn 200, Issue 6, 2015, Pages 374-393

  Nakamura, Ryosuke ^a   Nakamura, Fumio ^a   Fukunaga, Shigeharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Basement membrane; Cell culture; Extracellular matrix; Heparan sulfate; Proteoglycan

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; LAMININ; PERLECAN; TETRAZOLIUM; PROTEOHEPARAN SULFATE;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE CELL; CELL ACTIVITY; CELL ADHESION; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; KERATINOCYTE; LIVER CELL; MYOBLAST; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; BOVINE; CELL CULTURE; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; FIBROBLAST; MESENCHYMAL STROMA CELL; METABOLISM; SKELETAL MUSCLE CELL; WISTAR RAT;

ANIMALS; CATTLE; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLASTS; HEPARAN SULFATE PROTEOGLYCANS; KERATINOCYTES; MESENCHYMAL STROMAL CELLS; MUSCLE FIBERS, SKELETAL; RATS, WISTAR;

EID: 84951568746     PISSN: 14226405     EISSN: 14226421     Source Type: Journal    
DOI: 10.1159/000440950     Document Type: Article

References (86)

1. Abuharbeid, S., F. Czubayko, A. Aigner (2006) The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol 38: 1463-1468.
2. Al-Ahmad, A.J., B. Lee, M. Saini, G.J. Bix (2011) Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release. Glia 59: 1822-1840.
3. Arikawa-Hirasawa, E., H. Watanabe, H. Takami, J.R. Hassell, Y. Yamada (1999) Perlecan is essential for cartilage and cephalic development. Nat Genet 23: 354-358.
4. Aviezer, D., D. Hecht, M. Safran, M. Eisinger, G. David, A. Yayon (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79: 1005-1013.
5. Bajanca, F., M. Luz, K. Raymond, G.G. Martins, A. Sonnenberg, S. Tajbakhsh, M. Buckingham, S. Thorsteinsdottir (2006) Integrin 61-laminin interactions regulate early myotome formation in the mouse embryo. Development 133: 1635-1644.
6. Baker, A.B., D.S. Ettenson, M. Jonas, M.A. Nugen, R.V. Iozzo, E.R. Edelman (2008) Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-signaling pathway. Circ Res 103: 289-297.
7. Belleudi, F., L. Leone, V. Nobili, S. Raffa, F. Francescangeli, M. Maggi, S. Morrone, C. Marchese, M.R. Torrisi (2007) Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic 8: 1854-1872.
8. Bitter, T., H.M. Muir (1962) A modified uronic acid carbazole reaction. Anal Biochem 4: 330-334.
9. Bix, G.J. (2013) Perlecan domain V therapy for stroke: a beacon of hope ACS Chem Neurosci 4: 370-374.
10. Botta, A., F. Delteil, A. Mettouchi, A. Vieira, S. Estrach, L. Negroni, C. Stefani, E. Lemichez, G. Meneguzzi, L. Gagnoux-Palacios (2012) Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes. J Cell Sci 125: 4241-4252.
11. Brown, J.C., T. Sasaki, W. Gohring, Y. Yamada, R. Timpl (1997) The C-terminal domain V of perlecan promotes 1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur J Biochem 250: 39-46.
12. Bryant, D.M., K.E. Mostov (2008) From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol 9: 887-901.
13. Cailhier, J.F., I. Sirois, P. Laplante, S. Lepage, M.A. Raymond, N. Brassard, A. Prat, R.V. Iozzo, A.V. Pshezhetsky, M.J. Hebert (2008) Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem 283: 27220-27229.
14. Carpenter, G., S. Cohen (1979) Epidermal growth factor. Annu Rev Biochem 48: 193-216.
15. Chen, J.H., X.C. Wang, J.D. Sato (2001) Bifunctional effects of heparin-binding protein HBp17 on DNA synthesis in cells. Cell Biol Int 25: 567-570.
16. Chen, Q., J. Kon, H. Ooe, K. Sasaki, T. Mitaka (2007) Selective proliferation of rat hepatocyte progenitor cells in serum-free culture. Nat Protoc 2: 1197-1205.
17. Clark, R.A.F., M.G. Tonnesen, J. Gailit, D.A. Cheresh (1996) Transient functional expression of v3 on vascular cells during wound repair. Am J Pathol 148: 1407-1421.
18. Costell, M., R. Carmona, E. Gustafsson, M. Gonzalez-Iriarte, R. Fassler, R. Munoz-Chapuli (2002) Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91: 158-164.
19. Costell, M., E. Gustafsson, A. Aszodi, M. Morgelin, W. Bloch, E. Hunziker, K. Addicks, R. Timpl, R. Fassler (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147: 1109-1122.
20. De Wit, J., F. De Winter, J. Klooster, J. Verhaagen (2005) Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix. Mol Cell Neurosci 29: 40-55.
21. Declercq, H., N. Van den Vreken, E. De Maeyer, R. Verbeeck, E. Schacht, L. De Ridder, M. Cornelissen (2004) Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: comparison of different isolation techniques and source. Biomaterials 25: 757-768.
22. Fausto, N. (2000) Liver regeneration. J Hepatol 32: 19-31.
23. French, M.M., R.R. Gomes Jr., R. Timpl, M. Hook, K. Czymmek, M.C. Farach-Carson, D.D. Carson (2002) Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res 17: 48-55.
24. Garl, P.J., J.M. Wenzlau, H.A. Walker, J.M. Whitelock, M. Costell, M.C. Weiser-Evans (2004) Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN. Circ Res 94: 175-183.
25. Giros, A., J. Morante, C. Gil-Sanz, A. Fairen, M. Costell (2007) Perlecan controls neurogenesis in the developing telencephalon. BMC Dev Biol 7: 29.
26. Gosset, M., F. Berenbaum, S. Thirion, C. Jacques (2008) Primary culture and phenotyping of murine chondrocytes. Nat Protoc 3: 1253-1260.
27. Govindraj, P., L. West, T.J. Koob, P. Neame, K. Doege, J.R. Hassell (2002) Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. J Biol Chem 277: 19461-19469.
28. Guyton, J.R., R.D. Rosenberg, A.W. Clowes, M.J. Karnovsky (1980) Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 46: 625-634.
29. Hantaz-Ambroise, D., M. Vigny, J. Koenig (1987) Heparan sulfate proteoglycan and laminin mediate two different types of neurite outgrowth. J Neurosci 7: 2293-2304.
30. Hassell, J.R., P.G. Robey, H.J. Barrach, J. Wilczek, S.I. Rennard, G.R. Martin (1980) Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci USA 77: 4494-4498.
31. Hausman, D.B., M. DiGirolamo, T.J. Bartness, G.J. Hausman, R.J. Martin (2001) The biology of white adipocyte proliferation. Obes Rev 2: 239-254.
32. Hausman, D.B., H.J. Park, G.J. Hausman (2008) Isolation and culture of preadipocytes from rodent white adipose tissue. Methods Mol Biol 456: 201-219.
33. Hayashi, K., J.A. Madri, P.D. Yurchenco (1992) Endothelial cells interact with the core protein of basement membrane perlecan through 1 and 3 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol 114: 945-959.
34. Henry, M.D., J.S. Satz, C. Brakebusch, M. Costell, E. Gustafsson, R. Fassler, K.P. Campbell (2001) Distinct roles for dystroglycan, 1 integrin and perlecan in cell surface laminin organization. J Cell Sci 114: 1137-1144.
35. Housley, R.M., C.F. Morris, W. Boyle, B. Ring, R. Biltz, J.E. Tarpley, S.L. Aukerman, P.L. Devine, R.H. Whitehead, G.F. Pierce (1994) Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94: 1764-1777.
36. Iozzo, R.V. (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6: 646-656.
37. Iozzo, R.V., R.D. Sanderson (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15: 1013-1031.
38. Irie, A., H. Habuchi, K. Kimata, Y. Sanai (2003) Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun 308: 858-865.
39. Iruela-Arispe, M.L., G.E. Davis (2009) Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 16: 222-231.
40. Kimura, K., M. Iwano (2009) Molecular mechanisms of tissue fibrosis (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi 32: 160-167.
41. Knox, S., C. Merry, S. Stringer, J. Melrose, J. Whitelock (2002) Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J Biol Chem 277: 14657-14665.
42. Knox, S.M., J.M. Whitelock (2006) Perlecan: how does one molecule do so many things Cell Mol Life Sci 63: 2435-2445.
43. Laplante, P., M. Raymond, A. Labelle, J. Abe, R.V. Iozzo, M. Hebert (2006) Perlecan proteolysis induces an 21 integrin-and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J Biol Chem 281: 30383-30392.
44. Lee, B., D. Clarke, A. Al Ahmad, M. Kahle, C. Parham, L. Auckland, C. Shaw, M. Fidanboylu, A.W. Orr, O. Ogunshola, A. Fertala, S.A. Thomas, G.J. Bix (2011) Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest 121: 3005-3023.
45. Lee, S.W., M. Tanaka, S. Fukunaga, K. Takenouchi, F. Nakamura (2000) Immunohistological study of the localization of collagen types I-XI in bovine term placenta. Anim Sci J 71: 501-508.
46. Lichti, U., J. Anders, S.H. Yuspa (2008) Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Protoc 3: 799-810.
47. Lowry, O.H., N.J. Rosebrough, A.L. Farr, R.J. Randall (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
48. McCawley, L.J., P. O'Brien, L.P. Hudson (1998) Epidermal growth factor (EGF)-and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176: 255-265.
49. Metz, R.P., J.L. Patterson, E. Wilson (2012) Vascular smooth muscle cells: isolation, culture, and characterization. Methods Mol Biol 843: 169-176.
50. Mongiat, M., S.M. Sweeney, J.D. San Antonio, J. Fu, R.V. Iozzo (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278: 4238-4249.
51. Moore, B.B., M. Peters-Golden, P.J. Christensen, V. Lama, W.A. Kuziel, R. Paine 3rd, G.B. Toews (2003) Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE 2 . Am J Physiol Lung Cell Mol Physiol 284: L342-L349.
52. Murdoch, A.D., B. Liu, R. Schwarting, R.S. Tuan, R.V. Iozzo (1994) Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 42: 239-249.
53. Nakajima, I., S. Muroya, K. Chikuni (2003) Growth arrest by octanoate is required for porcine preadipocyte differentiation. Biochem Biophys Res Commun 309: 702-708.
54. Nakamura, F., S. Fujioka, Y. Hiraoka, Y. Kubo, S. Fukunaga (2000) Inhibitory effects of bovine cartilage chondromodulin-I on angiogenesis in vitro. Anim Sci J 71: 486-493.
55. Nakamura, H., T. Sugiura (1992) Kotai no Seiseiho; in Osaswa, T., Y. Okumura, J. Yada, K. Nagai (eds): Shin-Seikaagku Jikkenn Koza. Tokyo, Kagaku Dojin, vol 12, pp 13-32.
56. Nakamura, R., F. Nakamura, S. Fukunaga (2014a) Contrasting effect of perlecan on adipogenic and osteogenic differentiation of mesenchymal stem cells in vitro. Anim Sci J 85: 262-270.
57. Nakamura, R., F. Nakamura, S. Fukunaga (2014b) Changes in the composition of extracellular matrix accumulated by mesenchymal stem cells during in vitro expansion. Anim Sci J 85: 706-713.
58. Naldini, L., K.M. Weidner, E. Vigna, G. Gaudino, A. Bardelli, C. Ponzetto, R.P. Narsimhan, G. Hartmann, R. Zarnegar, G.K. Michalopoulos, et al. (1991) Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867-2878.
59. Nath, B., G. Szabo (2012) Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 55: 622-633.
60. Noonan, D.M., A. Fulle, P. Valente, S. Cai, E. Horigan, M. Sasaki, Y. Yamada, J.R. Hassell (1991) The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 266: 22939-22947.
61. Ohab, J.J., S. Fleming, A. Blesch, S.T. Carmichael (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26: 13007-13016.
62. Olson, N.E., S. Chao, V. Lindner, M.A. Reidy (1992) Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am J Pathol 140: 1017-1023.
63. Rando, T.A., H.M. Blau (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287.
64. Ritchey, E.R., K. Code, C.P. Zelinka, M.A. Scott, A.J. Fischer (2011) The chicken cornea as a model of wound healing and neuronal re-innervation. Mol Vis 17: 2440-2454.
65. Roberts, J., M.P. Kahle, G.J. Bix (2012) Perlecan and the blood-brain barrier: beneficial proteolysis Front Pharmacol 3: 155.
66. Rubin, J.S., A.M. Chan, D.P. Bottaro, W.H. Burgess, W.G. Taylor, A.C. Cech, D.W. Hirschfield, J. Wong, T. Miki, P.W. Finch, et al. (1991) A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88: 415-419.
67. Ruoslahti, E., J.C. Reed (1994) Anchorage dependence, integrins, and apoptosis. Cell 77: 477-478.
68. Sakai, K., K. Oka, K. Matsumoto, T. Nakamura (2010) p27 nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells. Biochem Biophys Res Commun 392: 403-408.
69. Salem, H.K., C. Thiemermann (2009) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596.
70. Santiago, B., E. Izquierdo, P. Rueda, M.J. Del Rey, G. Criado, A. Usategui, F. Arenzana-Seisdedos, J.L. Pablos (2012) CXCL12 isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation. Arthritis Rheum 64: 409-417.
71. Sasse, P., D. Malan, M. Fleischmann, W. Roell, E. Gustafsson, T. Bostani, Y. Fan, T. Kolbe, M. Breitbach, K. Addicks, A. Welz, G. Brem, J. Hescheler, A. Aszodi, M. Costell, W. Bloch, B.K. Fleischmann (2008) Perlecan is critical for heart stability. Cardiovasc Res 80: 435-444.
72. Seppanen, E., E. Roy, R. Ellis, G. Bou-Gharios, N.M. Fisk, K. Khosrotehrani (2013) Distant mesenchymal progenitors contribute to skin wound healing and produce collagen: evidence from a murine fetal microchimerism model. PLoS One 8: e62662.
73. Shapiro, F. (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15: 53-76.
74. Sharma, B., M. Handler, I. Eichstetter, J.M. Whitelock, M.A. Nugent, R.V. Iozzo (1998) Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest 102: 1599-1608.
75. Smola, H., H.J. Stark, G. Thiekotter, N. Mirancea, T. Krieg, N.E. Fusenig (1998) Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res 239: 399-410.
76. Spivak-Kroizman, T., M.A. Lemmon, I. Dikic, J.E. Ladbury, D. Pinchasi, J. Huang, M. Jaye, G. Crumley, J. Schlessinger, I. Lax (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79: 1015-1024.
77. Stratman, A.N., K.M. Malotte, R.D. Mahan, M.J. Davis, G.E. Davis (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114: 5091-5101.
78. Sun, K., C.M. Kusminski, P.E. Scherer (2011) Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101.
79. SundarRaj, N., D. Fite, S. Ledbetter, S. Chakravarti, J.R. Hassell (1995) Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 108: 2663-2672.
80. Sureshbabu, A., E. Tonner, D.J. Flint (2011) Insulin-like growth factor binding proteins and mammary gland development. Int J Dev Biol 55: 781-789.
81. Tran, P., K. Tran-Lundmark, R. Soininen, K. Tryggvason, J. Thyberg, U. Hedin (2004) Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 94: 550-558.
82. Voelkel, N.F., S. Mizuno, H.J. Bogaard (2013) The role of hypoxia in pulmonary vascular diseases: a perspective. Am J Physiol Lung Cell Mol Physiol 304: L457-L465.
83. Whitelock, J.M., L.D. Graham, J. Melrose, A.D. Murdoch, R.V. Iozzo, P.A. Underwood (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol 18: 163-178.
84. Whitelock, J.M., J. Melrose, R.V. Iozzo (2008) Diverse cell signaling events modulated by perlecan. Biochemistry 47: 11174-11183.
85. Whitelock, J.M., A.D. Murdoch, R.V. Iozzo, P.A. Underwood (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271: 10079-10086.
86. Zhou, Z., J. Wang, R. Cao, H. Morita, R. Soininen, K.M. Chan, B. Liu, Y. Cao, K. Tryggvason (2004) Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 64: 4699-4702.